PLXNYSE American

Protalix BioTherapeutics, Inc.

Alert me on PLX

Insider buys, 6 months

Congress trades, 6 months

Signals, 6 months

Six months

After each filing

Dec 23, 2025 Buy Bashan Dror Insider

1 week

+2.9%S&P −0.9%

1 month

+17.7%S&P +0.7%

3 months

+20.6%S&P −6.0%

6 months

+31.4%S&P +6.5%

Nov 20, 2025 Sale Bar-Shalev Amos Insider

1 week

+2.3%S&P +4.7%

1 month

+2.9%S&P +5.3%

3 months

+72.4%S&P +5.6%

6 months

+23.0%S&P +15.7%

Every purchase and sale on this ticker reported by a member of Congress or an insider, measured from the close of the first trading day after it became public to the close 1 week, 1 month, 3 months and 6 months later, each beside the S&P over the same days.

Filings for PLX

24 held · newest 524 held · newest 2

Loading the filings.

See all 24 filings for PLX

Aeon news and offers by email

New sources, new features and offers like our founding price. A few times a month at most. Stop any time.

Signal history

No signal for this ticker yet. A signal is written when insider buying here scores one dot or more.

Stakes

Oct 14, 2026 Schedule 13G

HOLD Alapkezelo Zrt.: 5.2%, 4,157,791 shares

Jun 30, 2026 Schedule 13G

BlackRock, Inc.: 5%, 4,046,650 shares

Mar 24, 2026 Schedule 13G, amended

MAK Capital Fund LP: 4.5%, 3,616,289 shares

Feb 26, 2026 Schedule 13G

MAK Capital Fund LP: 5.8%, 4,649,599 shares

Schedule 13D is filed within 5 business days of crossing 5 percent by an investor who may seek to influence the company. Schedule 13G is filed by a passive holder, and a large institution has up to 45 days after the quarter end.

Government contracts, last 12 months

Awards of $10M and up, from USAspending · context, not a signal

No contracts of $10M or more in the last 12 months.

Lobbying

Last four quarters

No lobbying reports on file.